Canal+ ups its stake in MultiChoice
France’s Canal+ Group has increased its stake in African pay TV company MultiChoice Group to more than 26%, having almost doubled its interest in the company over the past year.
Canal+ has gradually upped its stake in the South African company behind the DStv and GOtv pay TV platforms since it first acquired a 6.5% interest in October 2020.
A year ago, the Paris-based broadcasting giant announced that it owned 15% stake in MultiChoice; this rose to 18.44% in June this year, then 20.12% a month later.
A statement to the Johannesburg Stock Exchange (JSE) this week revealed that Canal+ has further increased this to 26.26%. Canal+ is owned by Vivendi, a mass media holding company that also owns Gameloft, Havas and Prisma Media.
As required by South Africa’s Companies Act, MultiChoice has filed the required notice with the JSE’s Takeover Regulation Panel. If Canal+ acquires a 35% interest in MutliChoice, it would trigger a mandatory offer to shareholders.
However, whether or not Canal+ and Vivendi owner Vincent Bollore intends to make an offer to acquire MultiChoice, it would face some major hurdles, given South Africa’s tight restrictions over the foreign ownership of broadcasters.
“While the group regularly engages investors and maintains an open dialogue with the investment community, its policy is not to comment on its individual shareholders, nor on its interactions with them,” said MultiChoice this week.
Canal+ and MultiChoice have worked together in recent years, coproducing shows such as the South African action-drama series Spinners (8×50’) and gritty Kenyan police procedural Crime & Justice, both made with MultiChoice’s streamer Showmax.
Showmax and Canal+’s African OTT platform MyCanal also coproduced 10-episode South African drama Blood Psalms, based on a pre-colonial Xhosa legend. Canal+ also operates Canal+ Afrique, an African version of Canal+ available mainly in the francophone countries of Central and West Africa.
MultiChoice is backed by African internet company Naspers.